MCID: TLG001
MIFTS: 27

Telogen Effluvium

Categories: Skin diseases

Aliases & Classifications for Telogen Effluvium

MalaCards integrated aliases for Telogen Effluvium:

Name: Telogen Effluvium 12 15 72 33

Classifications:



External Ids:

Disease Ontology 12 DOID:1943
ICD9CM 35 704.02
NCIt 50 C112200
SNOMED-CT 68 39479004
ICD10 33 L65.0
UMLS 72 C0263518

Summaries for Telogen Effluvium

MalaCards based summary : Telogen Effluvium is related to alopecia and androgenic alopecia. An important gene associated with Telogen Effluvium is DLGAP3 (DLG Associated Protein 3). The drugs Folic acid and Thiamine have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and thyroid.

Wikipedia : 75 Telogen effluvium is a scalp disorder characterized by the thinning or shedding of hair resulting from... more...

Related Diseases for Telogen Effluvium

Graphical network of the top 20 diseases related to Telogen Effluvium:



Diseases related to Telogen Effluvium

Symptoms & Phenotypes for Telogen Effluvium

Drugs & Therapeutics for Telogen Effluvium

Drugs for Telogen Effluvium (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
2
Thiamine Approved, Investigational, Nutraceutical, Vet_approved Phase 4 59-43-8, 70-16-6 1130
3
Pantothenic acid Approved, Nutraceutical, Vet_approved Phase 4 79-83-4 6613
4 Vitamin B9 Phase 4
5 Vitamin B Complex Phase 4
6 Folate Phase 4
7 Thiamin Phase 4
8 Ammonium trichloro(dioxoethylene-O,O'-)tellurate Phase 2
9 Adjuvants, Immunologic Phase 2
10 Anti-Infective Agents Phase 2
11 Protective Agents Phase 2
12 Radiation-Protective Agents Phase 2
13 Immunologic Factors Phase 2
14 Antiviral Agents Phase 2
15
Ergocalciferol Approved, Nutraceutical 50-14-6 5280793
16
Vitamin D Approved, Nutraceutical, Vet_approved 1406-16-2
17
Calcium Approved, Nutraceutical 7440-70-2 271
18 Plasminogen Activator Inhibitor 1
19 Micronutrients
20 Trace Elements
21 Vitamins
22 Nutrients
23 Hormones
24 Ergocalciferols
25 Vitamin D2
26 Calciferol
27 Bone Density Conservation Agents
28 Calcium, Dietary

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Randomized Clinical Trial, Placebo Controlled and Active Comparator, to Evaluate Efficacy and Safety of Neosil in Chronic Effluvium Recruiting NCT03659201 Phase 4 Neosil complete;Pantogar;Neosil
2 Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women Unknown status NCT00418249 Phase 2 AS101
3 Controlled, Randomized, Double Blind Study, for the Evaluation of Tolerance and Trichological Efficacy of a Food Supplement: Bioscalin® New Formulation Versus Reference Formulation Currently on the Market and Placebo Completed NCT03272750
4 Evaluating PAI-1 Expression in the Hair Follicles of Patients With Non-scarring Hair Loss. Recruiting NCT02548689
5 Demonstration of the Presence of Carbonyl Stress in the Hair Follicles of Women With Reactive Hair Loss Not yet recruiting NCT03414476
6 Role of Vitamin D in Androgenetic Alopecia Not yet recruiting NCT03154528

Search NIH Clinical Center for Telogen Effluvium

Genetic Tests for Telogen Effluvium

Anatomical Context for Telogen Effluvium

MalaCards organs/tissues related to Telogen Effluvium:

41
Skin, Bone, Thyroid, Testes, Spinal Cord

Publications for Telogen Effluvium

Articles related to Telogen Effluvium:

(show top 50) (show all 284)
# Title Authors PMID Year
1
Preliminary results of the use of scalp microneedling in different types of alopecia. 38
31254437 2019
2
Focal atrichia: A diagnostic clue in female pattern hair loss. 38
29017840 2019
3
"Miliacin encapsulated by polar lipids stimulates cell proliferation in hair bulb and improves telogen effluvium in women". 38
31135099 2019
4
Treatment of telogen effluvium using a dietary supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera: Results of an observational study. 38
30693615 2019
5
Alopecia in Cronkhite-Canada syndrome: Is it truly telogen effluvium? 38
31056741 2019
6
Expert consensus on the management of Telogen Effluvium in India. 38
31360038 2019
7
New pattern hair loss in young Turkish women; What's wrong in their daily life? 38
30614076 2019
8
The use of phosphodiesterase inhibitors for the treatment of alopecia. 38
30935254 2019
9
Off-Label Use of Topical Minoxidil in Alopecia: A Review. 38
30604379 2019
10
Effects of isotretinoin on the hair cycle. 38
30350907 2019
11
HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. 38
30394586 2019
12
The role of photobiomodulation when associated with microneedling in female pattern hair loss: A randomized, double blind, parallel group, three arm, clinical study protocol. 38
30896659 2019
13
Beau lines and telogen effluvium following aluminium phosphide poisoning. 38
30845132 2019
14
Postfebrile telogen effluvium: hair fall after Rickettsia conorii infection. 38
28704990 2019
15
NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. 38
29774652 2019
16
Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort. 38
30455235 2019
17
The influence of methotrexate on hair loss while using immunomodulatory doses. 38
30830893 2019
18
Research on the Balance of Thiol-Disulfide in Blood Serum in Women with Telogen Effluvium. 38
30820129 2019
19
Scalp biopsy identifies systemic amyloidosis presenting as isolated telogen effluvium: A case report. 38
31105951 2019
20
Cystine-thiamin-containing hair-growth formulation modulates the response to UV radiation in an in vitro model for growth-limiting conditions of human keratinocytes. 38
30466067 2018
21
Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation 38
30500148 2018
22
Common causes of paediatric alopecia 38
31195774 2018
23
Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time. 38
30307062 2018
24
Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus. 38
29948959 2018
25
White and yellow dots as new trichoscopic signs of severe female androgenetic alopecia in dark skin phototypes. 38
30043983 2018
26
Color-transition sign: A useful trichoscopic finding for differentiating alopecia areata incognita from telogen effluvium. 38
29512186 2018
27
Naked Hair Shafts as a Marker of Cicatricial Alopecia. 38
29293128 2018
28
A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. 38
29945259 2018
29
New multi-targeting strategy in hair growth promotion: in vitro and in vivo studies. 38
29766701 2018
30
Horizontal and vertical sections of scalp biopsy specimens from dermatomyositis patients with scalp involvement. 38
29409918 2018
31
Assessment of Heavy Metal and Trace Element Levels in Patients with Telogen Effluvium. 38
29937562 2018
32
Localized Telogen Effluvium Following Hair Transplantation. 38
29606820 2018
33
Proprietary Herbal Extract Downregulates the Gene Expression of IL-1α in HaCaT Cells: Possible Implications Against Nonscarring Alopecia. 38
30302033 2018
34
Elastic Staining in Differentiating Between Follicular Streamers and Follicular Scars in Horizontal Scalp Biopsy Sections. 38
28816743 2018
35
Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells. 38
30186771 2018
36
Non-scarring Alopecias in Iranian Patients: A Histopathological Study With Hair Counts. 38
30636954 2018
37
Telogen Effluvium: Is There a Need for a New Classification? A Reply. 38
29457010 2018
38
Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium. 38
30237729 2018
39
Alopecias in lupus erythematosus. 38
30397497 2018
40
The Role of Vitamin D in Non-Scarring Alopecia. 38
29215595 2017
41
Physiologic changes of pregnancy: A review of the literature. 38
29234716 2017
42
Three Cases of Hair Loss Analyzed by the Point of View of the Analytical Psychology. 38
29118523 2017
43
Exogen Hairs in Women with and without Hair Loss. 38
29177147 2017
44
Syphilitic Alopecia: Case Reports and Trichoscopic Findings. 38
29177154 2017
45
Hair Loss: Common Causes and Treatment. 38
28925637 2017
46
Eccrine Duct Dilation as a Marker of Cicatricial Alopecia. 38
27673387 2017
47
Syphilitic alopecia: uncommon trichoscopic findings. 38
29085722 2017
48
Prevalence of Nutritional Deficiencies in Hair Loss among Indian Participants: Results of a Cross-sectional Study. 38
28932059 2017
49
Suprabulbar Thinning of Hair in Telogen Effluvium. 38
28332382 2017
50
Telogen effluvium as first clinical presentation of dengue. 38
25800885 2017

Variations for Telogen Effluvium

Expression for Telogen Effluvium

Search GEO for disease gene expression data for Telogen Effluvium.

Pathways for Telogen Effluvium

GO Terms for Telogen Effluvium

Sources for Telogen Effluvium

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....